Suppr超能文献

在改良的沙门氏菌回复突变试验中使用人肝癌细胞系Hep G2。

Use of the human liver cell line Hep G2 in a modified Salmonella reversion assay.

作者信息

Zhuo Z, Casciano D A, Heflich R H

出版信息

Cancer Lett. 1986 Sep;32(3):327-34. doi: 10.1016/0304-3835(86)90186-2.

Abstract

The human hepatoma cell line Hep G2 was used to activate promutagenic chemicals to mutagens in a modified Salmonella typhimurium reversion assay. Hep G2 cells mediated positive mutagenic responses in tester strain TA98 with 5 and 25 micrograms/plate of 2-aminofluorene, but these responses were consistently lower than those seen using primary rat hepatocytes. In addition, 3 and 6 X 10(6) Hep G2 cells per assay produced positive mutagenic responses with 2-aminoanthracene, benzidine, acetylbenzidine and aflatoxin B1, while benzo[a]pyrene, 7,12-dimethylbenz[a]anthracene, 3-methylcholanthrene, 4-aminobiphenyl and 4- and 11-aminobenzo[a]pyrene were nonmutagenic with Hep G2-cell activation. These results indicate that Hep G2 cells may be a useful intact cellular metabolizing system of human origin for predicting the genotoxicity of promutagenic agents, but that the use of Salmonella as a target cell may limit the classes of mutagens detected.

摘要

在改良的鼠伤寒沙门氏菌回复突变试验中,用人肝癌细胞系Hep G2将前诱变剂化学物质激活为诱变剂。Hep G2细胞在测试菌株TA98中,对每平板5微克和25微克的2-氨基芴介导了阳性诱变反应,但这些反应始终低于使用原代大鼠肝细胞时所观察到的反应。此外,每次试验中3×10⁶和6×10⁶个Hep G2细胞对2-氨基蒽、联苯胺、乙酰联苯胺和黄曲霉毒素B1产生了阳性诱变反应,而苯并[a]芘、7,12-二甲基苯并[a]蒽、3-甲基胆蒽、4-氨基联苯以及4-氨基苯并[a]芘和11-氨基苯并[a]芘经Hep G2细胞激活后无诱变作用。这些结果表明,Hep G2细胞可能是一种有用的源自人类的完整细胞代谢系统,用于预测前诱变剂的遗传毒性,但以沙门氏菌作为靶细胞可能会限制所检测到的诱变剂类别。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验